Posted by Michael Wonder on 27 Apr 2018
FDA moves to encourage A.I. in medicine, drug development
26 April 2018 - It is establishing a new incubator focused on health technology.
The FDA is making moves to encourage the use of artificial intelligence and other digital tools in medicine and drug development, expanding a program it announced last year around digital health and establishing a new incubator focused on health technology.
"AI holds enormous promise for the future of medicine," FDA Commissioner Scott Gottlieb said in prepared remarks for the Health Datapalooza conference Thursday in Washington. "We're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies."
